Absci reports business updates and second quarter 2023 financial and operating results

Entered into partnership with google ventures-backed biotech company to discover innovative new medicines entered into collaboration with caltech, supported by the gates foundation, to discover affordable hiv therapeutic vaccinations vancouver, wash. and new york, aug. 14, 2023 (globe newswire) -- absci corporation (nasdaq: absi), a generative ai drug creation company, today reported financial and operating results for the quarter ended june 30, 2023.
ABSI Ratings Summary
ABSI Quant Ranking